Abstract:Genome-wide associations studies (GWAS) have identified >400 loci associated with common human diseases. Despite the extraordinary achievement that these results represent, several questions remain unanswered: (i) What is the contribution of rare variants to common diseases not addressed by GWAS? (ii) What are the functional variants underlying the GWAS associations? To answer these questions, we first explored the role of common and rare variants in morbid obesity (BMI>40) by identifying all the variants in the intervals of two endocannabinoid metabolic genes (MGLL and FAAH) using targeted sequencing. We used two different statistical approaches (single marker tests and collapsed markers tests) to identify variants in four intervals associated with high BMI. The majority of the associated variants are located in promoter sequences or in predicted transcriptional enhancers, suggesting their regulatory role. Additionally, we demonstrate that the set of rare variants in the FAAH promoter associated with BMI are also associated with an increased level of anandamide, a FAAH substrate, further suggesting a functional role in obesity. In a second study, we examined one of the most compelling GWAS that had identified SNPs in the 9p21 gene desert associated with coronary artery disease (CAD) and Type 2 diabetes (T2D). We identified 33 enhancers in 9p21; the interval is the second most dense gene-desert for predicted enhancers and is six times denser than the whole genome. The activity of three of these enhancers is affected by regulatory variants that show allelic differences in DNA-protein affinity and are strongly associated with either CAD or T2D. Some of these variants are predicted to disrupt the transcription-binding site relevant to CAD biology. Our study shows that the 9p21 gene desert is significantly enriched in enhancer elements and suggests the associations with CAD and T2D likely result from the cumulative contributions of multiple regulatory variants. Taken together, our studies show that a comprehensive approach of human genetics that integrates rare variants and functional knowledge, such as regulatory elements or metabolic and cell-specific effects, can leverage the findings of GWAS and lead to a deeper functional understanding of the role of genetic variation in human diseases.

Using multi-scale genomics to associate poorly annotated genes with rare diseases

Joint, multifaceted genomic analysis enables diagnosis of diverse, ultra-rare monogenic presentations

Identification Of Sequence Variants In Genetic Disease-Causing Genes Using Targeted Next-Generation Sequencing

Diagnostic and Clinical Utility of Whole Genome Sequencing in a Cohort of Undiagnosed Chinese Families with Rare Diseases

DNA Language Model and Interpretable Graph Neural Network Identify Genes and Pathways Involved in Rare Diseases

Structural and non-coding variants increase the diagnostic yield of clinical whole genome sequencing for rare diseases

Advancing long-read nanopore genome assembly and accurate variant calling for rare disease detection

A Copernican Revolution of Multigenic Analysis: A Retrospective Study on Clinical Exome Sequencing in Unclear Genetic Disorders

Integration of transcriptomics and long-read genomics prioritizes structural variants in rare disease

Improved Detection of Rare Genetic Variants for Diseases

Targeted Next-generation Sequencing and Bioinformatics Pipeline to Evaluate Genetic Determinants of Constitutional Disease

Deciphering the genetic basis of common diseases by integrated functional annotation of common and rare variants

Identifying pathogenic variants in rare pediatric neurological diseases using exome sequencing

Combining exome/genome sequencing with data repository analysis reveals novel gene–disease associations for a wide range of genetic disorders

Evaluation of an Automated Genome Interpretation Model for Rare Disease Routinely Used in a Clinical Genetic Lab

Large-Scale Validation of Single Nucleotide Polymorphisms in Gene Regions

Genetic associations of protein-coding variants in human disease

Meta-analysis of Gene-Level Tests for Rare Variant Association.

Mapping structural variants to rare disease genes using long-read whole genome sequencing and trait-relevant polygenic scores

Prioritization of Nonsynonymous Single Nucleotide Variants for Exome Sequencing Studies Via Integrative Learning on Multiple Genomic Data